Report: Endo devices replacing open surgery
Endovascular surgical techniques may outshine conventional open methods, according to a Frost & Sullivan analysis, “Endovascular Surgical Intervention—Technology Market Penetration Analysis.” The analysis outlined how intravascular balloons, stents and coils for varied endo procedures have become the wave of the future and have provided alternatives to CABG, carotid endarterectomy (CEA) and aneurysm clipping procedures.
For instance, the CREST (Carotid Revascularization Endarterectomy versus Stent Trial) study has addressed whether carotid artery stenting may be a good alternative to CEA. Post-trial results, FDA has approved the procedure for both high-risk and moderate-risk patients. These types of noninvasive procedures, along with developments in stent graft technology, have provided more flexible delivery systems that are safer and have fewer complications than more invasive types of procedures.
Frost & Sullivan reported that by 2015, the global market for endovascular abdominal aortic aneurysm (AAA) repair is set to reach $1.6 billion. The market was valued at $1 billion in 2010. The report outlined that endovascular repair will find a large place in AAA, particularly because nearly 4.5 million people suffer from the disease.
“Endovascular repair has also become a widely accepted treatment for aortic aneurysms, with penetration rates reaching 80 percent in the best centers; however, overall penetration rates in the developed world are still below 30 percent,” according to Frost & Sullivan. The company said that one way to increase these rates is to develop interactive and informative web portals to educate patients about various treatment options.
“The importance of greater patient awareness becomes evident when, despite increased patient screening for aneurysms, the lack of understanding of AAAs often results in late detections,” according to the analysis. Graft technologies can decrease morbidity by 11 percent when compared with open endovascular techniques.
The analysis is part of Frost & Sullivan’s Technical Insights subscription. Frost & Sullivan's Technical Insights research group is an international technology analysis business that develops technical news alerts, newsletters and research services.
For instance, the CREST (Carotid Revascularization Endarterectomy versus Stent Trial) study has addressed whether carotid artery stenting may be a good alternative to CEA. Post-trial results, FDA has approved the procedure for both high-risk and moderate-risk patients. These types of noninvasive procedures, along with developments in stent graft technology, have provided more flexible delivery systems that are safer and have fewer complications than more invasive types of procedures.
Frost & Sullivan reported that by 2015, the global market for endovascular abdominal aortic aneurysm (AAA) repair is set to reach $1.6 billion. The market was valued at $1 billion in 2010. The report outlined that endovascular repair will find a large place in AAA, particularly because nearly 4.5 million people suffer from the disease.
“Endovascular repair has also become a widely accepted treatment for aortic aneurysms, with penetration rates reaching 80 percent in the best centers; however, overall penetration rates in the developed world are still below 30 percent,” according to Frost & Sullivan. The company said that one way to increase these rates is to develop interactive and informative web portals to educate patients about various treatment options.
“The importance of greater patient awareness becomes evident when, despite increased patient screening for aneurysms, the lack of understanding of AAAs often results in late detections,” according to the analysis. Graft technologies can decrease morbidity by 11 percent when compared with open endovascular techniques.
The analysis is part of Frost & Sullivan’s Technical Insights subscription. Frost & Sullivan's Technical Insights research group is an international technology analysis business that develops technical news alerts, newsletters and research services.